Related Experiment Video
Updated: Mar 1, 2026

08:20
Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
7.0K
Targeting Gene Function in Germinal Center B Cells: A Practical Approach
Valentina Petrocelli1, Stefano Casola2
1The FIRC Institute of Molecular Oncology Foundation (IFOM), 20139, Milan, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|June 8, 2017
Summary
Understanding germinal center (GC) B cell function is vital for treating immune disorders and improving vaccines. This study details methods for conditional gene targeting in GC B cells using the Cre/loxP system.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- The germinal center (GC) reaction is critical for adaptive immunity.
- GC B cell dysfunction leads to autoimmune diseases, lymphomas, and infections.
- Understanding GC B cell molecular control is key for disease treatment and vaccine development.
Purpose of the Study:
- To describe essential features of GC B cell-specific gene targeting experiments.
- To provide guidance on Cre transgene selection and experimental controls.
- To outline strategies for overcoming Cre/loxP system limitations and optimizing research.
Main Methods:
- Utilizing the Cre/loxP recombination system for conditional gene manipulation in GC B cells.
- Selecting appropriate Cre transgenes and implementing necessary controls.
- Developing strategies to mitigate Cre/loxP system leakiness.
Main Results:
- Conditional gene targeting accelerates the understanding of GC B cell genetic networks.
- Previous studies highlight advantages and limitations of Cre/loxP in GC B cells.
- The described approaches aim to minimize animal use and expedite analysis.
Conclusions:
- Effective gene targeting in GC B cells is crucial for advancing immunology and medicine.
- Optimized Cre/loxP strategies enhance research efficiency and reliability.
- This work provides a framework for future studies on GC B cell-related diseases and therapies.
Related Concept Videos
B Cell Activation and Differentiation
17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Diversity of Antigen Receptors
1.8K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.8K
T Cell Activation and Clonal Selection
16.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.7K
Hybridoma Technology
18.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.0K
Cells of the Adaptive Immune Response
9.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.5K

